25 related articles for article (PubMed ID: 38642214)
21. Multiple-matrix metabolomics analysis for the distinct detection of colorectal cancer and adenoma.
Zhang Y; Ni M; Tao Y; Shen M; Xu W; Fan M; Shan J; Cheng H
Metabolomics; 2024 Apr; 20(3):47. PubMed ID: 38642214
[TBL] [Abstract][Full Text] [Related]
22. Current and future molecular diagnostics in colorectal cancer and colorectal adenoma.
Tsang AH; Cheng KH; Wong AS; Ng SS; Ma BB; Chan CM; Tsui NB; Chan LW; Yung BY; Wong SC
World J Gastroenterol; 2014 Apr; 20(14):3847-57. PubMed ID: 24744577
[TBL] [Abstract][Full Text] [Related]
23. The association between nonalcoholic fatty liver disease and risk of colorectal adenoma and cancer incident and recurrence: a meta-analysis of observational studies.
Chen J; Bian D; Zang S; Yang Z; Tian G; Luo Y; Yang J; Xu B; Shi J
Expert Rev Gastroenterol Hepatol; 2019 Apr; 13(4):385-395. PubMed ID: 30791768
[TBL] [Abstract][Full Text] [Related]
24. Metabolomics in diagnosis and biomarker discovery of colorectal cancer.
Zhang A; Sun H; Yan G; Wang P; Han Y; Wang X
Cancer Lett; 2014 Apr; 345(1):17-20. PubMed ID: 24333717
[TBL] [Abstract][Full Text] [Related]
25.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
